바이오모아 (BioMoa) — ADC · Antibody

9268프로그램 35FDA 승인

166오늘 방문

738누적 방문

8122갱신 대기 S–CData Tier S/A/B차세대 1068HER2 breast 5456Antibody 2744CGT →Psoriasis →NSCLC 35FDA 승인

피드 Data Tier 차세대

최근 활동

RSS →

CGTAAVBiologicstaleSpark Therapeutics, Inc.Phase 1

AAV8-hFIX19 (AAV8-hFIX19)

Hemophilia B · Hemophilia B

#HemophiliaB#CGT#Phase1#세포유전치료#CAR-T+2

임상시험 1상태 DISCONTINUED

ADCBiologicstaleCancer Institute and Hospital, …Phase 2

LYC001 (LYC001)

Rare Malignant Neoplasm; Advanced Solid Tumors · Rare Malignant Neoplasm

#RareMalignantNeoplasm#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

임상시험 1상태 RECRUITING

ADCBiologicstaleAdcentrx TherapeuticsPhase 1

ADRX-0405 (ADRX-0405)

Solid Tumors · Solid Tumors

#SolidTumors#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1

임상시험 1상태 RECRUITING

CGTBiologicstaleBeacon TherapeuticsPhase 2

rAAV2tYF-PR1.7-hCNGB3 (rAAV2tYF-PR1.7-hCNGB3)

Achromatopsia · Achromatopsia

#Achromatopsia#CGT#Phase2#세포유전치료#CAR-T+2

임상시험 1상태 RECRUITING

CGTBiologicstaleUltragenyx Pharmaceutical IncPhase 2

scAAV8OTC (scAAV8OTC)

Ornithine Transcarbamylase (OTC) Deficiency · Ornithine Transcarbamylase (OTC) Deficie

#OrnithineTranscarbamylaseOTCDefi#CGT#Phase2#세포유전치료#CAR-T+2

임상시험 1상태 ACTIVE

ADCBiologicstaleCancer Institute and Hospital, …Phase 2

CE120 (CE120)

Rare Malignant Neoplasm; Advanced Solid Tumors · Rare Malignant Neoplasm

#RareMalignantNeoplasm#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

임상시험 1상태 RECRUITING

CGTBiologicstaleThe Affiliated Hospital of Xuzh…Phase 2

ASCT+CAR-T Cell Infusion (ASCT+CAR-T Cell Infusion)

B-cell Lymphoma · B-cell Lymphoma

#B-cellLymphoma#CGT#Phase2#세포유전치료#CAR-T+2

임상시험 1상태 ACTIVE

AntibodystaleRochePhase 3

serplulimab、bevacizumab (serplulimab、bevacizumab)

Rectal Cancer · Rectal Cancer

#RectalCancer#Antibody#Phase3#항체#면역항체+2

임상시험 1상태 RECRUITING

CGTAAVBiologicstaleWeill Medical College of Cornel…Phase 1

AAVrh.10CUhCLN2 vector 9.0x10^11 genome copies (AAVrh.10CUhCLN2 vector 9.0x10^11 genome copies)

Batten Disease; Late-Infantile Neuronal Ceroid Lipofuscinosis · Batten Disease

#BattenDisease#CGT#Phase1#세포유전치료#CAR-T+3

임상시험 1상태 ACTIVE

AntibodystaleRochePhase 1

trastuzumab (Herceptin, Trastuzumab Rezatecan and Retlirafusp alfa)

Gastric or Gastroesophageal Junction Adenocarcinoma · Gastric or Gastroesophageal Junction Ade

#GastricorGastroesophagealJunctio#Antibody#Phase1#항체#면역항체+2

임상시험 1상태 RECRUITING

AntibodystaleJiangsu HengRui Medicine Co., L…Phase 3

Ramucirumab / Paclitaxel/ Docetaxel/ Irinotecan (Ramucirumab / Paclitaxel/ Docetaxel/ Irinotecan)

HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma · HER2

#HER2#Antibody#Phase3#항체#면역항체+3

임상시험 1상태 RECRUITING

AntibodystaleFudan UniversityPhase 2

trastuzumab (Herceptin, Taxanes combined with trastuzumab and pertuzumab.)

Advanced HER2-positive Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+3

효능 ORR 91.8%임상시험 1상태 RECRUITING

CGTAAVBiologicstaleElisigen, Inc.Phase 2

NG101 AAV gene therapy (NG101 AAV gene therapy)

Age-Related Macular Degeneration · Age-Related Macular Degeneration

임상시험 1상태 RECRUITING

CGTBiologicstaleNationwide Children's HospitalPhase 1

rAAV1.tMCK.human-alpha-sarcoglycan- First cohort (rAAV1.tMCK.human-alpha-sarcoglycan- First cohort)

Muscular Dystrophies · Muscular Dystrophies

#MuscularDystrophies#CGT#Phase1#세포유전치료#CAR-T+2

임상시험 1상태 ACTIVE

ADCBiologicstaleLigaChem Biosciences, Inc.Phase 2

LCB02A (LCB02A)

Advanced Solid Tumors · Advanced Solid Tumors

#AdvancedSolidTumors#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1

임상시험 1상태 RECRUITING

CGTBiologicstaleNationwide Children's HospitalPhase 1

d3990 (rAAV2.5-CMV-minidystrophin, rAAV2.5-CMV-minidystrophin (d3990))

Duchenne Muscular Dystrophy · Duchenne Muscular Dystrophy

#DuchenneMuscularDystrophy#CGT#Phase1#세포유전치료#CAR-T+2

임상시험 1상태 ACTIVE

CGTAAVBiologicstaleFederal State Budget Institutio…Phase 2

GT-UGT1A1-AAV8-02 (GT-UGT1A1-AAV8-02)

Crigler-Najjar Syndrome Type I · Crigler-Najjar Syndrome Type I

#Crigler-NajjarSyndromeTypeI#CGT#Phase2#세포유전치료#CAR-T+2

임상시험 1상태 RECRUITING

CGTBiologicstaleM.D. Anderson Cancer CenterPhase 1

TGFBR2 KO iC9/TROP2.CAR/IL-15 NK cells (TGFBR2 KO iC9/TROP2.CAR/IL-15 NK cells)

Breast Cancer · TROP2

#TROP2#CGT#Phase1#세포유전치료#CAR-T+3

임상시험 1상태 RECRUITING

ADCBiologicstaleCSPC ZhongQi Pharmaceutical Tec…Phase 1

an antibody drug conjugate (an antibody drug conjugate)

Neoplasms · Neoplasms

#Neoplasms#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1

효능 ORR 31.2%임상시험 1상태 ACTIVE

CGTBiologicstaleBeacon TherapeuticsPhase 2

rAAV2tYF-CB-hRS1 (rAAV2tYF-CB-hRS1)

X-linked Retinoschisis · X-linked Retinoschisis

#X-linkedRetinoschisis#CGT#Phase2#세포유전치료#CAR-T+2

효능 ORR 39.5%임상시험 1상태 ACTIVE

CGTBiologicstaleSTZ eyetrialPhase 2

rAAV.hCNGA3 (rAAV.hCNGA3)

Achromatopsia · Achromatopsia

#Achromatopsia#CGT#Phase2#세포유전치료#CAR-T+2

임상시험 1상태 RECRUITING

AntibodystaleUniversity of ColognePhase 2

Oxaliplatin, Capecitabine, Bevacizumab, Imatinib (Oxaliplatin, Capecitabine, Bevacizumab, Imatinib)

Stage IV Colorectal Cancer · Stage IV Colorectal Cancer

#StageIVColorectalCancer#Antibody#Phase2#항체#면역항체+2

임상시험 1상태 ACTIVE

AntibodystaleGoethe UniversityPhase 2

MabCampath (Alemtuzumab, Alemtuzumab (MabCampath))

Adult Acute Lymphocytic Leukemia T-cell; Lymphoma, Lymphoblastic · Adult Acute Lymphocytic Leukemia T-cell

#AdultAcuteLymphocyticLeukemiaT-c#Antibody#Phase2#항체#면역항체+4

임상시험 1상태 ACTIVE

CGTAAVBiologicstaleREGENXBIO Inc.Phase 2

AAV directed hLDLR gene therapy (AAV directed hLDLR gene therapy)

Homozygous Familial Hypercholesterolemia (HoFH) · Homozygous Familial Hypercholesterolemia

#HomozygousFamilialHypercholester#CGT#Phase2#세포유전치료#CAR-T+2

임상시험 1상태 DISCONTINUED

AntibodystaleFudan UniversityPhase 2

trastuzumab (Herceptin, Paclitaxel polymer micelles combined with trastuzumab, pertuzumab, and adrelumab)

Advanced HER2-positive Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+3

임상시험 1상태 RECRUITING

80 / 167 페이지

← 이전 다음 →

전체 9,268개 프로그램 보기

갱신 기록 없음 · 14일 주기 · 방문 166 / 738

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

추천 비교

최근 활동

빠른 검색 · 이슈 태그

AAV8-hFIX19 (AAV8-hFIX19)

LYC001 (LYC001)

ADRX-0405 (ADRX-0405)

rAAV2tYF-PR1.7-hCNGB3 (rAAV2tYF-PR1.7-hCNGB3)

scAAV8OTC (scAAV8OTC)

CE120 (CE120)

ASCT+CAR-T Cell Infusion (ASCT+CAR-T Cell Infusion)

serplulimab、bevacizumab (serplulimab、bevacizumab)

AAVrh.10CUhCLN2 vector 9.0x10^11 genome copies (AAVrh.10CUhCLN2 vector 9.0x10^11 genome copies)

trastuzumab (Herceptin, Trastuzumab Rezatecan and Retlirafusp alfa)

Ramucirumab / Paclitaxel/ Docetaxel/ Irinotecan (Ramucirumab / Paclitaxel/ Docetaxel/ Irinotecan)

trastuzumab (Herceptin, Taxanes combined with trastuzumab and pertuzumab.)

NG101 AAV gene therapy (NG101 AAV gene therapy)

rAAV1.tMCK.human-alpha-sarcoglycan- First cohort (rAAV1.tMCK.human-alpha-sarcoglycan- First cohort)

LCB02A (LCB02A)

d3990 (rAAV2.5-CMV-minidystrophin, rAAV2.5-CMV-minidystrophin (d3990))

GT-UGT1A1-AAV8-02 (GT-UGT1A1-AAV8-02)

TGFBR2 KO iC9/TROP2.CAR/IL-15 NK cells (TGFBR2 KO iC9/TROP2.CAR/IL-15 NK cells)

an antibody drug conjugate (an antibody drug conjugate)

rAAV2tYF-CB-hRS1 (rAAV2tYF-CB-hRS1)

rAAV.hCNGA3 (rAAV.hCNGA3)

Oxaliplatin, Capecitabine, Bevacizumab, Imatinib (Oxaliplatin, Capecitabine, Bevacizumab, Imatinib)

MabCampath (Alemtuzumab, Alemtuzumab (MabCampath))

AAV directed hLDLR gene therapy (AAV directed hLDLR gene therapy)

trastuzumab (Herceptin, Paclitaxel polymer micelles combined with trastuzumab, pertuzumab, and adrelumab)

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

추천 비교

최근 활동

빠른 검색 · 이슈 태그

실시간 이슈 · 검색

AAV8-hFIX19 (AAV8-hFIX19)

LYC001 (LYC001)

ADRX-0405 (ADRX-0405)

rAAV2tYF-PR1.7-hCNGB3 (rAAV2tYF-PR1.7-hCNGB3)

scAAV8OTC (scAAV8OTC)

CE120 (CE120)

ASCT+CAR-T Cell Infusion (ASCT+CAR-T Cell Infusion)

serplulimab、bevacizumab (serplulimab、bevacizumab)

AAVrh.10CUhCLN2 vector 9.0x10^11 genome copies (AAVrh.10CUhCLN2 vector 9.0x10^11 genome copies)

trastuzumab (Herceptin, Trastuzumab Rezatecan and Retlirafusp alfa)

Ramucirumab / Paclitaxel/ Docetaxel/ Irinotecan (Ramucirumab / Paclitaxel/ Docetaxel/ Irinotecan)

trastuzumab (Herceptin, Taxanes combined with trastuzumab and pertuzumab.)

NG101 AAV gene therapy (NG101 AAV gene therapy)

rAAV1.tMCK.human-alpha-sarcoglycan- First cohort (rAAV1.tMCK.human-alpha-sarcoglycan- First cohort)

LCB02A (LCB02A)

d3990 (rAAV2.5-CMV-minidystrophin, rAAV2.5-CMV-minidystrophin (d3990))

GT-UGT1A1-AAV8-02 (GT-UGT1A1-AAV8-02)

TGFBR2 KO iC9/TROP2.CAR/IL-15 NK cells (TGFBR2 KO iC9/TROP2.CAR/IL-15 NK cells)

an antibody drug conjugate (an antibody drug conjugate)

rAAV2tYF-CB-hRS1 (rAAV2tYF-CB-hRS1)

rAAV.hCNGA3 (rAAV.hCNGA3)

Oxaliplatin, Capecitabine, Bevacizumab, Imatinib (Oxaliplatin, Capecitabine, Bevacizumab, Imatinib)

MabCampath (Alemtuzumab, Alemtuzumab (MabCampath))

AAV directed hLDLR gene therapy (AAV directed hLDLR gene therapy)

trastuzumab (Herceptin, Paclitaxel polymer micelles combined with trastuzumab, pertuzumab, and adrelumab)

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

추천 비교

최근 활동

빠른 검색 · 이슈 태그

실시간 이슈 · 검색

AAV8-hFIX19 (AAV8-hFIX19)

LYC001 (LYC001)

ADRX-0405 (ADRX-0405)

rAAV2tYF-PR1.7-hCNGB3 (rAAV2tYF-PR1.7-hCNGB3)

scAAV8OTC (scAAV8OTC)

CE120 (CE120)

ASCT+CAR-T Cell Infusion (ASCT+CAR-T Cell Infusion)

serplulimab、bevacizumab (serplulimab、bevacizumab)

AAVrh.10CUhCLN2 vector 9.0x10^11 genome copies (AAVrh.10CUhCLN2 vector 9.0x10^11 genome copies)

trastuzumab (Herceptin, Trastuzumab Rezatecan and Retlirafusp alfa)

Ramucirumab / Paclitaxel/ Docetaxel/ Irinotecan (Ramucirumab / Paclitaxel/ Docetaxel/ Irinotecan)

trastuzumab (Herceptin, Taxanes combined with trastuzumab and pertuzumab.)

NG101 AAV gene therapy (NG101 AAV gene therapy)

rAAV1.tMCK.human-alpha-sarcoglycan- First cohort (rAAV1.tMCK.human-alpha-sarcoglycan- First cohort)

LCB02A (LCB02A)

d3990 (rAAV2.5-CMV-minidystrophin, rAAV2.5-CMV-minidystrophin (d3990))